Oxra 10 Mg Tablet (Dapagliflozin)

Description

Introduction

Oxra 10 Mg Tablet is an oral tablet identified as containing 10 mg of dapagliflozin. Its stated indication is type 2 diabetes. Dapagliflozin belongs to a group of medicines called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It helps lower blood glucose through its action in the kidneys. A healthcare professional can determine whether this medicine fits a person’s treatment plan.

What Is It?

Dapagliflozin is a prescription medicine used to manage type 2 diabetes. Oxra is identified as a 10 mg tablet; its inactive ingredients and any special tablet coating have not been verified. Anyone who needs to check the full ingredient list because of an allergy or intolerance should ask a pharmacist to review the supplied pack.

This tablet does not contain insulin. Diabetes care may also involve other medicines, monitoring, food choices and physical activity. The approach depends on the person’s medical history and treatment goals.

How Does It Work?

The kidneys normally filter glucose from the blood and return much of it to the bloodstream. SGLT2 is one of the proteins involved in this process. Dapagliflozin blocks SGLT2, allowing more glucose to leave the body in urine. This can reduce blood glucose in people with type 2 diabetes.

The same action can increase urine output and affect fluid balance. Dapagliflozin does not directly stimulate insulin release. Its effects and risks still need consideration alongside any other diabetes medicines a person uses.

Common Uses

Oxra is identified for type 2 diabetes. Dapagliflozin may be prescribed alone or with other glucose-lowering medicines when a clinician considers the combination appropriate. It helps control blood glucose but does not cure diabetes.

Dapagliflozin is also used for certain heart failure and chronic kidney disease conditions. Those uses have not been verified for this specific Oxra product and should not be assumed to be approved indications for it. Ask a healthcare professional for product-specific guidance.

Available Strengths

This family is available in 5 mg, 10 mg.

Key Features

• Identified active ingredient: dapagliflozin.
• Identified strength: 10 mg per tablet.
• Oral tablet formulation.
• Belongs to the SGLT2 inhibitor medicine class.
• Increases the amount of glucose passed in urine.
• Stated product indication: type 2 diabetes.

Benefits

• Dapagliflozin can help lower blood glucose in type 2 diabetes.
• Its glucose-lowering action does not rely on directly increasing insulin release.
• It may be used alongside another diabetes medicine when the combination is clinically appropriate.
• Its effects can be assessed through the monitoring plan agreed with a healthcare professional.

Possible Side Effects

• Genital fungal infections, including thrush, can occur. Symptoms may include itching, redness or unusual discharge.
• Passing urine more often is possible. Increased fluid loss can contribute to thirst, dizziness or low blood pressure.
• Urinary tract infections can occur. Burning when passing urine, fever or feeling unwell should be assessed.
• Low blood glucose is more likely when dapagliflozin is combined with insulin or a sulfonylurea such as gliclazide.
• Diabetic ketoacidosis is an uncommon but serious risk. Nausea, vomiting, abdominal pain, unusual tiredness or difficulty breathing need urgent medical attention, even when blood glucose is not markedly high.
• Severe allergic reactions and serious infection around the genitals or perineum are rare but require urgent medical care.

Precautions

• Tell a healthcare professional about kidney or liver problems, low blood pressure, or previous reactions to dapagliflozin.
• Discuss recurrent urinary or genital infections before starting treatment.
• Dapagliflozin is not a substitute for insulin. Type 1 diabetes needs separate assessment and treatment.
• Vomiting, diarrhoea, fever or reduced food and fluid intake can increase the risks of dehydration and ketoacidosis. Ask about a sick-day plan.
• Discuss pregnancy, plans to become pregnant or breastfeeding with a healthcare professional.

Additional Precautions

• Tell the treating team about dapagliflozin before surgery or a procedure involving fasting. They can advise whether treatment should be paused.
• Discuss a ketogenic diet, prolonged fasting or heavy alcohol intake with a clinician because these circumstances may increase the risk of ketoacidosis.
• Kidney function, blood pressure and blood glucose may need review during treatment, particularly when health or other medicines change.
• Seek prompt assessment for severe pain, swelling or redness around the genitals or perineum, especially with fever or feeling unwell.

Storage Instructions

• Keep tablets in their original packaging and out of the sight and reach of children.
• Protect them from excess heat and moisture.
• Check the supplied pack or ask a pharmacist for the exact storage conditions and expiry date for Oxra.
• Ask a pharmacist how to dispose of expired or unwanted tablets safely.

How to Take

• Follow the directions on the dispensing label and any instructions supplied with the medicine.
• Dapagliflozin tablets are swallowed by mouth and can generally be taken with or without food.
• Ask a pharmacist or prescriber about a missed dose. Do not take a double dose to make up for one missed.
• Discuss changes to treatment with the prescriber. Stopping dapagliflozin may cause blood glucose to rise.
• Ask a healthcare professional for individual guidance on monitoring and managing treatment during illness.

Drug Interactions

• Insulin and sulfonylureas, including gliclazide, can increase the risk of low blood glucose when used with dapagliflozin.
• Diuretics, such as furosemide, may add to fluid loss or low blood pressure.
• Other medicines that lower blood pressure may increase the chance of dizziness or low blood pressure.
• Lithium treatment may need review because dapagliflozin can affect lithium levels.
• Tell a pharmacist or prescriber about all prescription medicines, non-prescription products and supplements being used.

Why Choose This Product?

• It provides the identified 10 mg dapagliflozin strength in tablet form.
• Dapagliflozin has an established mechanism for lowering blood glucose in type 2 diabetes.
• Its suitability depends on clinical assessment, including kidney function, other medicines and potential adverse effects.

Frequently Asked Questions (FAQs)

What is the active ingredient in Oxra 10 Mg Tablet?

The identified active ingredient is dapagliflozin, with a stated strength of 10 mg per tablet.

Is Oxra an insulin medicine?

No. Dapagliflozin is an SGLT2 inhibitor that acts through the kidneys. It does not replace prescribed insulin.

What condition is identified for this product?

Its stated indication is type 2 diabetes. Ask a healthcare professional about any other proposed use for this specific product.

Can dapagliflozin tablets be taken with food?

They can generally be taken with or without food. Follow the directions supplied with the dispensed medicine.

Can this medicine cause low blood glucose?

The risk is greater when dapagliflozin is used with insulin or a sulfonylurea. A clinician can advise on monitoring.

Why might urination increase?

Dapagliflozin allows more glucose to leave the body in urine and can increase urine output.

What if I become unwell while taking it?

Vomiting, diarrhoea, fever or reduced intake can increase certain risks. Contact a healthcare professional for sick-day guidance.

Are genital infections possible?

Yes. Genital fungal infections are a recognised side effect. Seek assessment if symptoms develop.

How should the tablets be stored?

Keep them in their original packaging, away from excess heat and moisture, and out of children’s reach. Check the pack for exact conditions.

Can treatment stop when blood glucose improves?

Discuss any change with the prescriber. Improved readings alone do not establish that treatment is no longer needed.

Related Products

• Oxra 5 mg Tablet (Dapagliflozin)
• Oxra 10 Mg Tablet (Dapagliflozin)
• Acarbose 50 mg Australia
• Repaglinide 0.5 mg Australia
• Bromocriptine 1.25 mg Australia
• Sitagliptin 100 Mg Australia